Abbott Laboratories (NYSE:ABT) is included among the 15 Best Dividend Growth Stocks to Buy Now. On October 24, Citi a‌nalyst ...

There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show ...

Carillon Tower Advisers, an investment management company, released its “Carillon Eagle Growth & Income Fund” third-quarter ...

Abbott Laboratories (NYSE:ABT) operates a broad business spanning four main areas: medical devices, established pharmaceuticals, diagnostics, and nutrition. With a strong global presence, its ...

Abbott Laboratories (NYSE:ABT) reported muted sales in the third quarter on Wednesday and narrowed its fiscal 2025 guidance. The company reported third-quarter sales of $11.37 billion, slightly ...

We recently published 10 Stocks Jim Cramer Discussed As He Warned About Big Risk To Big Tech. Abbott Laboratories (NYSE:ABT) is one of the stocks Jim Cramer recently discussed. Abbott Laboratories ...

Invst LLC lessened its position in Abbott Laboratories (NYSE:ABT – Free Report) by 6.9% in the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange ...

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them. ← Back to Full Coverage: S&P 500 (NYSEARCA: SPY) Live: ...

The company shared new real-world findings for Aveir DR at the Asia Pacific Heart Rhythm Society (APHRS). These add to strong ...

Key Insights Significantly high institutional ownership implies Abbott Laboratories' stock price is sensitive to ...

Breaking down segments: Medical Devices led with 12% growth (Diabetes Care +19.5%, Heart Failure +14%, Structural Heart +12%). Nutrition +3.5% (Adult +6.5% on Ensure/Glucerna). EPD +8% (Key 15 markets ...